Back to Infectious Diseases or Bioterror Introduction
REFERENCES & LINKS
Readers are especially referred to the JAMA series on biological weapons, from which this writer has borrowed heavily. The JAMA articles and other critical articles are *starred below and most are available in full (including photographs) at the CDC Bioterror site: http://www.bt.cdc.gov/ or at the Johns Hopkins University Biodefense site: http://www.hopkins-biodefense.org/. Additional information on these and other BW agents is available at the Federation of American Scientists site: http://www.fas.org/index.html
*Arnon, S.S., Schecter, R., Inglesby, T.V., Henderson, D.A., Bartlett, J.G., Ascher, M.S., Eitzen, E., Fine, A.D., Hauer, J., Layton, M., Lillibridge, S., Osterholm, M.T., O'Toole, T., Parker, G., Perl, T.M., Russell, P.K., Swerdlow, D.L., & Tonat, K. (2001). Botulinum toxin as a biological weapon: Medical and public health management. JAMA, The Journal of the American Medical Association, 285(8), 1059-1070.
Bardi, J. (1999). Aftermath of a hypothetical smallpox disaster. Emerging Infectious Diseases, 5(4), 557-551.
Broad, W.J. & Peterson, M. (2001). Defense may be inadequate for germ or toxic attacks. New York Times. Accessed 9/23/2001 http://www.nytimes.com/2001/09/23/national/23GERM.html
Burrows, W.D., & Renner, S.E. (1999). Biological warfare agents as threats to potable water. Environmental Health Perspectives. 107(12), 975-84.
*Centers for Disease Control and Prevention. (2000). Biological and chemical terrorism: Strategic plan for preparedness and response. MMWR: Morbidity and Mortality Weekly Report, 49(RR-4), 1-14.
*Centers for Disease Control and Prevention. (1999). Bioterrorism alleging use of anthrax and interim guidelines for management-United States, 1998. MMWR: Morbidity and Mortality Weekly Report, 48(4), 69-74.
Cieslak, T.J. & Eitzen, E.M. (2000). Bioterrorism: Agents of concern. Journal of Public Health Management Practice. 6(4), 19-29.
Cieslak, T.J., & Eitzen, E.M. (1999). Clinical and epidemiologic principles of anthrax. Emerging Infectious Diseases, 5(4), 552-555.
*Cieslak, T.J., Rowe, J.R., Kortepeter, M.G., Madsen, J.M., Newmark, J., Christopher, G.W., Culpepper, R.C., & Eitzen, E.M. (2000). A field-expedient algorithmic approach to the clinical management of chemical and biological casualties. Military Medicine. 165(9), 659-662.
Dao, J. (2001). Defense Secretary Warns of Unconventional Attacks. New York Times. Accessed 10/01/2001 http://www.nytimes.com/2001/10/01/national/01CAPI.html
Davis, C.J. (1999). Nuclear blindness: An overview of the biological weapons programs of the former Soviet Union and Iraq. Emerging Infectious Diseases, 5(4), 509-512.
*Dennis, D.T., Inglesby, T.V., Henderson, D.A., Bartlett, J.G., Ascher, M.S., Eitzen, E., Fine, A.D., Friedlander, A.M., Hauer, J., Layton, M., Lillibridge, S.R., McDade, J., Osterholm, M.T., O'Toole, T., Parker, G., Pen, T.M., Russell, P.K., & Tonat, K. (2001).Tularemia as a biological weapon: Medical and public health management. JAMA, The Journal of the American Medical Association, 285(21), 2763-2773.
Dennis, D.T. (2000).
Tularemia. In G.T. Strickland (Ed.), Hunter's tropical medicine and emerging
infectious diseases (8th ed.) (pp. 411-415). Philadelphia: W.B. Saunders.
Franz, D.R. & Zajtchuk, R.. (2000). Biological terrorism: understanding
the threat, preparation, and medical response. Disease of the Month.
46(2), 125-190.
Friedlander AM. (2000). Anthrax: Clinical features, pathogenesis, and potential biological warfare threat. Current Clinical Topics in Infectious Diseases, 20, 335-349.
Garrett, L.C., Magruder, C., & Molgard, C.A. (2000). Taking the terror out of bioterrorism: Planning for a bioterrorist event from a local perspective. Journal of Public Health Management Practice. 6(4), 1-7.
Heddurshetti, R., Pumpradit, W., & Lutwick, L.I. (2001). Pulmonary manifestations of bioterrorism. Current Infectious Disease Reports. 3(3), 249-257.
*Henderson, D.A., Inglesby, T.V., Bartlett, J.G., Ascher, M.S., Eitzen, E., Jahrling, P.B., Hauer, J., Layton, M., McDade, J., Osterhoim, M.T., O'Toole, T., Parker, G., Perl, T., Russell, P.K., & Tonat, K. (1999). Smallpox as a biological weapon: Medical and public health management. JAMA, The Journal of the American Medical Association, 281(22), 2127-2137.
Henderson, D.A. (1999). Smallpox: Clinical and epidemiologic features. Emerging Infectious Diseases, 5(4), 537-539.
Henry, L. (2001). Inhalation anthrax: Threat clinical presentation, and treatment. Journal of the American Academy of Nurse Practitioners, 13(4), 164-168.
*Inglesby, T.V., Dennis, D.T., Henderson, D.A., Bartlett, J.G., Ascher, M.S., Eitzen, E., Fine, A.D., Friedlander, A.M., Hauer, J., Koerner, J.F., Layton, M., McDade, J., Osterholm, M.T., O'Toole, T., Parker, G., Perl, T.M., Russell, P.K., Schoch-Spana, M., Tonat, K. (2000). Plague as a biological weapon: medical and public health management. JAMA, The Journal of the American Medical Association, 283(17), 2281-2290.
*Inglesby, T.V., Henderson, D.A., Bartlett, J.G., Ascher, M.S., Eitzen, E., Friedlander, A.M., Hauer, J., McDade, J., Osterholm, M.T., O'Toole, T., Parker, G., Perl, T.M., Russell, P.K., & Tonat, K.. (1999). Anthrax as a biological weapon: Medical and public health management. JAMA, The Journal of the American Medical Association, 282(17), 1624-1625.
Johns Hopkins University Center for Civilian Biodefense Studies. (2000). Accessed 9/24/2001 http://www.hopkins-biodefense.org/
Khan, A.S., Morse, S. & Lillibridge, S. (2000). Publis health preparedness for biological terrorism in the USA. The Lancet, 356(9236), 1179-1182.
Kortepeter, M.G. & Parker, G.W. (1999). Potential biological weapons threats. Emerging Infectious Diseases, 5(4), 523-527.
Mabee, M.S. (2001). CSTE Washington Report. 5(15). Accessed 9/24/2001 http://www.cste.org/washingtonrpt/010730Washrpt.asp
*Macintyre, A.G., Christopher, G.W., Eitzen, E., Gum, R., Weir, S., DeAtley, C., Tonat, K. & Barbera, J.A. (2000). Weapons of mass destruction events with contaminated cauaties: Effective planning for health care facilities. JAMA, The Journal of the American Medical Association, 283(2), 242-249.
McGovern, T.W., Christopher, G.W., & Eitzen, E.M. (1999; ). Cutaneous manifestations of biological warfare and related threat agents. Archives of Dermatology. 135, 311-322.
Moser, R., White, G.L., Lewis-Younger, C.R., & Garrett, L.C. (2001). Preparing for expected bioterrorism attacks. Military Medicine. 166(5):369-374.
Sanger, D.E. & Kahn, J.H. (September 25, 2001). Bush freezes assets linked to terror network. New York Times. Accessed 9/24/2001 http://www.nytimes.com/2001/09/25/international/25CAPI.html
Schecter, R. & Arnon, S.S. (2000). Extreme potency of botulinum toxin. The Lancet, 355(9199), 237-238.
Shafazand, S., Doyle, R., Ruoss, S., Weinacker, A., & Raffin, T.A., (1999). Inhalational anthrax: epidemiology, diagnosis, and management. Chest, 116(5), 1369-1376.
Shoham, D. (2000). Iraq's biological warfare agents: A comprehensive analysis. Critical Reviews in Microbiology, 26(3), 179-204.
Siegelson, H.J. (2000). Aftermath…Hospitals are on the front lines after acts of terrorism. Are you prepared? Health Facilities Management, 13(1), 24-28.
Terriff, C.M. & Tee, A.M. (2001). Citywide pharmaceutical preparation for bioterrorism. American Journal of Hospital Systems Pharmacies. 58(3), 233-237.
Titball, R.W. & Leary, S.E. (1998). Plague. British Medical Bulletin, 54(3), 625-633.
U.S. Congress, Office of Technology Assessment. (1993). Proliferation of weapons of mass destruction. Washington D.C.: U.S. Government Printing Office. Publication OTA-ISC-559.
Waekerle, J.F. (2000). Domestic preparedness for events involving weapons of mass destruction. JAMA, The Journal of the American Medical Association, 283(2), 252-254.
Wetter, D.C., Daniell, W.E., Treser, C.D. (2001). Hospital preparedness for victims of chemical or biological terrorism. American Journal of Public Health, 91(5), 710-716.
World Health Organization Group of Consultants. (1970). Health aspects of chemical and biological weapons. Geneva: Author.